BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9186829)

  • 1. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C.
    Nishioka M; Morshed SA; Kono K; Himoto T; Parveen S; Arima K; Watanabe S; Manns MP
    J Hepatol; 1997 May; 26(5):992-1000. PubMed ID: 9186829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients.
    Parez N; Herzog D; Jacqz-Aigrain E; Homberg JC; Alvarez F
    Clin Exp Immunol; 1996 Nov; 106(2):336-43. PubMed ID: 8918582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.
    Yamamoto AM; Cresteil D; Homberg JC; Alvarez F
    Gastroenterology; 1993 Jun; 104(6):1762-7. PubMed ID: 7684716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to P450IID6, SLA, PDH-E2 and BCKD-E2 in Japanese patients with chronic hepatitis.
    Nishioka M; Morshed SA; Parveen S; Kono K; Matsuoka H; Manns MP
    J Gastroenterol Hepatol; 1997 Dec; 12(12):862-8. PubMed ID: 9504898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
    Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
    Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
    Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
    Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
    J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
    Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
    Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
    Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
    Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
    Czaja AJ; Carpenter HA; Manns MP
    Gastroenterology; 1993 Nov; 105(5):1522-8. PubMed ID: 8224657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-organ specific autoantibodies in children with chronic hepatitis C.
    Bortolotti F; Vajro P; Balli F; Giacchino R; Crivellaro C; Barbera C; Cataleta M; Muratori L; Pontisso P; Nebbia G; Zancan L; Bertolini A; Alberti A; Bianchi F
    J Hepatol; 1996 Nov; 25(5):614-20. PubMed ID: 8938535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
    Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
    J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
    Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
    J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
    Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
    Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.